Form 4 for BBNX Beta Bionics, Inc.
Accepted 2025-09-04 00:00:00 ET · period of report 2025-09-02 · accession 0001415889-25-023742 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-04 | 2025-09-02 | BBNX | Feider Stephen | CFO | S - Sale | $18.86 | -1,462 | 44.0K | -3% | -$27.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-02 | S | D | 1,462 | $18.86 | 44,041 | D | — | — | (F2) The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |